Cochrane Abstracts
Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review
Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Remacemide for Drug-resistant Localization Related Epilepsy: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Oral_anticoagulants_versus_antiplatelet_therapy_for_preventing_stroke_in_patients_with_non_valvular_atrial_fibrillation_and_no_history_of_stroke_or_transient_ischemic_attacks:_Cochrane_systematic_review. Accessed 02 December 2022.
Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Oral_anticoagulants_versus_antiplatelet_therapy_for_preventing_stroke_in_patients_with_non_valvular_atrial_fibrillation_and_no_history_of_stroke_or_transient_ischemic_attacks:_Cochrane_systematic_review. Accessed December 2, 2022.
Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Oral_anticoagulants_versus_antiplatelet_therapy_for_preventing_stroke_in_patients_with_non_valvular_atrial_fibrillation_and_no_history_of_stroke_or_transient_ischemic_attacks:_Cochrane_systematic_review
Remacemide for Drug-resistant Localization Related Epilepsy: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2022 December 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Oral_anticoagulants_versus_antiplatelet_therapy_for_preventing_stroke_in_patients_with_non_valvular_atrial_fibrillation_and_no_history_of_stroke_or_transient_ischemic_attacks:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Remacemide for drug-resistant localization related epilepsy: Cochrane systematic review
ID - 434228
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434228/all/Oral_anticoagulants_versus_antiplatelet_therapy_for_preventing_stroke_in_patients_with_non_valvular_atrial_fibrillation_and_no_history_of_stroke_or_transient_ischemic_attacks:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
